Open-Source Artificial Pancreas System Use Among People With Type 1 Diabetes Mellitus in China
Launched by THIRD AFFILIATED HOSPITAL, SUN YAT-SEN UNIVERSITY · Oct 5, 2023
Trial Information
Current as of November 10, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into how well an open-source artificial pancreas system (APS) works for people with Type 1 Diabetes Mellitus (T1DM) in China. The study aims to understand the current use of this technology and how it affects blood sugar control in patients. The researchers want to gather information about the effectiveness of the APS and any factors that might influence its success.
To participate in this trial, you need to be diagnosed with T1DM and have been using an open-source APS for at least three months. You also need to be willing to provide consent to take part in the study and share your experiences. There are no specific exclusions based on your health, so if you meet the inclusion criteria and live in China, you could be eligible. Participants will help researchers learn more about the benefits of this system, which may improve diabetes management for many people.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. diagnosed T1DM.
- • 2. Currently use open-source APS for at least 3 months.
- • 3. Willing and able to provide informed consent (or be a parent or other legally authorized representative) and to provide the data.
- • 4. reside in China.
- Exclusion Criteria:
- • None
About Third Affiliated Hospital, Sun Yat Sen University
The Third Affiliated Hospital of Sun Yat-sen University is a leading medical institution in China, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its comprehensive resources and multidisciplinary expertise to facilitate cutting-edge studies that aim to improve patient outcomes and contribute to the global body of medical knowledge. With a focus on collaboration and patient-centered care, the Third Affiliated Hospital is dedicated to fostering advancements in medical science and ensuring the highest standards of ethical practice in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Jinhua Yan, PHD,MD
Principal Investigator
Third Affiliated Hospital, Sun Yat-Sen University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported